Assessment of the Effect of Overexpression of Death-Associated Protein Kinases 3 Using PEGFPN1 on Gastric Adenocarcinoma Cell Line (MKN45)
Open Access
- 13 August 2022
- journal article
- research article
- Published by Brieflands in International Journal of Cancer Management
- Vol. 15 (6)
Abstract
Background: Gastric cancer (GC) is one of the most common malignancies worldwide. An in-depth understanding of the molecular mechanisms that underlies tumor GC will lead to breakthroughs in the targeted treatment of GC. Based on multiple lines of evidence, death-associated protein kinase 3 (DAPK3) regulates both programmed cell death including apoptosis and autophagy. The widespread experimental evidence raises the possibility of using DAPK-based gene therapy strategies. Objectives: The aim of this study was to investigate the effect of overexpression of DAPK3 using the PEGFPN1 vector on the gastric adenocarcinoma cell line (MKN45). Methods: The MKN45 cell lines were cultured in a DMEM culture medium and, then, the recombinant vector PEGFPN1-DAPK3 was transfected into the cells by lipofectamine 2000. The effects of the overexpression of the DAPK3 gene on MKN45 cells were evaluated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT), flow cytometry, and real-time quantitative reverse transcription PCR (qRT-PCR) techniques. Results: Our findings indicated that overexpression of DAPK3 in MKN45 cells not only affects the expression of apoptosis-related genes but also changes the expression of autophagy-related genes. Additionally, overexpression of DAPK3 reduces the metabolic activity of cells. Conclusions: The overexpression of the DAPK3 gene can lead to cell death by both inducing apoptosis and autophagy pathways in the gastric adenocarcinoma cell line (MKN45). This anti-cancer activity may describe a hopeful strategy in the application of novel gene therapy for the treatment of gastric adenocarcinoma; however, further research is required to examine the clinical effectiveness of this strategy in GC treatment.Keywords
This publication has 30 references indexed in Scilit:
- DAPK3 inhibits gastric cancer progression via activation of ULK1-dependent autophagyCell Death & Differentiation, 2020
- DAPK1 (death associated protein kinase 1) mediates mTORC1 activation and antiviral activities in CD8+ T cellsCellular & Molecular Immunology, 2019
- Orange is the new black: Kinases are the new master regulators of tumor suppressionIUBMB Life, 2018
- Death‐associated protein kinase (DAPK) family modulators: Current and future therapeutic outcomesMedicinal Research Reviews, 2018
- The RNA binding protein tristetraprolin down-regulates autophagy in lung adenocarcinoma cellsExperimental Cell Research, 2018
- Chemotherapy for advanced gastric cancerCochrane Database of Systematic Reviews, 2017
- Activation of AKT negatively regulates the pro-apoptotic function of death-associated protein kinase 3 (DAPK3) in prostate cancerCancer Letters, 2016
- A novel in vitro system for intracellular delivery of nonviral DNAJournal of Orthopaedic Translation, 2014
- Zipper interacting protein kinase (ZIPK): function and signalingApoptosis, 2013
- Atg1‐mediated myosin II activation regulates autophagosome formation during starvation‐induced autophagyThe EMBO Journal, 2010